KR102198130B1 - 바소프레신-2 수용체 작용제 - Google Patents
바소프레신-2 수용체 작용제 Download PDFInfo
- Publication number
- KR102198130B1 KR102198130B1 KR1020167003247A KR20167003247A KR102198130B1 KR 102198130 B1 KR102198130 B1 KR 102198130B1 KR 1020167003247 A KR1020167003247 A KR 1020167003247A KR 20167003247 A KR20167003247 A KR 20167003247A KR 102198130 B1 KR102198130 B1 KR 102198130B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- peptide
- alkyl
- mmol
- dmf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC(CCCCN(*)C(N)=CC=I=C)=O Chemical compound CC(CCCCN(*)C(N)=CC=I=C)=O 0.000 description 2
- MUJJALQVNDXTIQ-PFAGHSOOSA-N CC(C)[C@@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CSCCCC(N[C@@H](Cc(cc1)ccc1Cl)C(N[C@H]1Cc2ccc[s]2)=O)=O)C(N(CCC2)[C@@H]2C(N[C@H](CCCNC(N)=N)C(NC2CC2)=O)=O)=O)=O)=O)NC1=O Chemical compound CC(C)[C@@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CSCCCC(N[C@@H](Cc(cc1)ccc1Cl)C(N[C@H]1Cc2ccc[s]2)=O)=O)C(N(CCC2)[C@@H]2C(N[C@H](CCCNC(N)=N)C(NC2CC2)=O)=O)=O)=O)=O)NC1=O MUJJALQVNDXTIQ-PFAGHSOOSA-N 0.000 description 1
- VEFXJYXHOJJJST-TXZSMETKSA-N CC(C)[C@@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CSCCCC(N[C@@H](Cc(cc1)ccc1O)C(N[C@H]1Cc2ccc[s]2)=O)=O)C(N(CCC2)[C@@H]2C(N[C@H](CCCNC(N)=N)CO)=O)=O)=O)=O)NC1=O Chemical compound CC(C)[C@@H](C(N[C@@H](CC(N)=O)C(N[C@@H](CSCCCC(N[C@@H](Cc(cc1)ccc1O)C(N[C@H]1Cc2ccc[s]2)=O)=O)C(N(CCC2)[C@@H]2C(N[C@H](CCCNC(N)=N)CO)=O)=O)=O)=O)NC1=O VEFXJYXHOJJJST-TXZSMETKSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361859024P | 2013-07-26 | 2013-07-26 | |
| US61/859,024 | 2013-07-26 | ||
| US201461952073P | 2014-03-12 | 2014-03-12 | |
| US61/952,073 | 2014-03-12 | ||
| PCT/US2014/048317 WO2015013690A1 (en) | 2013-07-26 | 2014-07-25 | Vasopressin-2 receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20160034943A KR20160034943A (ko) | 2016-03-30 |
| KR102198130B1 true KR102198130B1 (ko) | 2021-01-05 |
Family
ID=51398870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020167003247A Expired - Fee Related KR102198130B1 (ko) | 2013-07-26 | 2014-07-25 | 바소프레신-2 수용체 작용제 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US10131692B2 (https=) |
| EP (1) | EP3024829B1 (https=) |
| JP (1) | JP6387095B2 (https=) |
| KR (1) | KR102198130B1 (https=) |
| CN (1) | CN105492441B (https=) |
| AU (1) | AU2014292860B2 (https=) |
| BR (1) | BR112016000436B1 (https=) |
| CA (1) | CA2919208A1 (https=) |
| DK (1) | DK3024829T3 (https=) |
| EA (1) | EA029392B1 (https=) |
| ES (1) | ES2656039T3 (https=) |
| HR (1) | HRP20180009T1 (https=) |
| HU (1) | HUE035252T2 (https=) |
| IL (1) | IL243730B (https=) |
| JO (1) | JO3371B1 (https=) |
| LT (1) | LT3024829T (https=) |
| MX (1) | MX363355B (https=) |
| MY (1) | MY183429A (https=) |
| PH (1) | PH12016500044A1 (https=) |
| PL (1) | PL3024829T3 (https=) |
| PT (1) | PT3024829T (https=) |
| RS (1) | RS56604B1 (https=) |
| SG (1) | SG11201600031RA (https=) |
| SI (1) | SI3024829T1 (https=) |
| TW (1) | TWI640542B (https=) |
| WO (1) | WO2015013690A1 (https=) |
| ZA (1) | ZA201600145B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102176900B (zh) | 2008-09-17 | 2017-09-26 | 克艾思马有限公司 | 药物组合物和相关的给药方法 |
| CA3037581A1 (en) | 2016-10-21 | 2018-04-26 | Chiasma, Inc. | Terlipressin compositions and their methods of use |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995001373A1 (en) | 1993-06-29 | 1995-01-12 | Ferring B.V. | Process for manufacture of 1-deamino-8-d-arginine vasopressin |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE399252B (sv) * | 1976-05-24 | 1978-02-06 | Ferring Ab | Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin 4-d-arginin8-vasopressin |
| CA1246055A (en) * | 1980-03-24 | 1988-12-06 | Joseph H. Cort | N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs |
| DK153883A (da) | 1982-04-20 | 1983-10-21 | Ceskoslovenska Akademie Ved | Vasopressin-analoge |
| SE501677C2 (sv) * | 1993-06-18 | 1995-04-10 | Ferring Bv | Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel |
| CZ292131B6 (cs) | 2000-02-16 | 2003-08-13 | Ústav organické chemie a biochemie AV ČR | Synthetické analogy Desmopressinu chráněné v C-terminální sekvenci proti karboxyamidasovému štěpení |
| JP6131120B2 (ja) * | 2013-06-19 | 2017-05-17 | 株式会社パイオラックス | コネクタ |
-
2014
- 2014-07-24 JO JOP/2014/0234A patent/JO3371B1/ar active
- 2014-07-25 CN CN201480041380.1A patent/CN105492441B/zh not_active Expired - Fee Related
- 2014-07-25 DK DK14755464.6T patent/DK3024829T3/en active
- 2014-07-25 PL PL14755464T patent/PL3024829T3/pl unknown
- 2014-07-25 MX MX2016000525A patent/MX363355B/es unknown
- 2014-07-25 CA CA2919208A patent/CA2919208A1/en not_active Abandoned
- 2014-07-25 BR BR112016000436-1A patent/BR112016000436B1/pt not_active IP Right Cessation
- 2014-07-25 MY MYPI2016700251A patent/MY183429A/en unknown
- 2014-07-25 ES ES14755464.6T patent/ES2656039T3/es active Active
- 2014-07-25 EA EA201690219A patent/EA029392B1/ru not_active IP Right Cessation
- 2014-07-25 SI SI201430496T patent/SI3024829T1/en unknown
- 2014-07-25 WO PCT/US2014/048317 patent/WO2015013690A1/en not_active Ceased
- 2014-07-25 JP JP2016530091A patent/JP6387095B2/ja not_active Expired - Fee Related
- 2014-07-25 AU AU2014292860A patent/AU2014292860B2/en not_active Ceased
- 2014-07-25 EP EP14755464.6A patent/EP3024829B1/en active Active
- 2014-07-25 HR HRP20180009TT patent/HRP20180009T1/hr unknown
- 2014-07-25 TW TW103125533A patent/TWI640542B/zh not_active IP Right Cessation
- 2014-07-25 SG SG11201600031RA patent/SG11201600031RA/en unknown
- 2014-07-25 PT PT147554646T patent/PT3024829T/pt unknown
- 2014-07-25 US US14/647,357 patent/US10131692B2/en active Active
- 2014-07-25 RS RS20171214A patent/RS56604B1/sr unknown
- 2014-07-25 KR KR1020167003247A patent/KR102198130B1/ko not_active Expired - Fee Related
- 2014-07-25 HU HUE14755464A patent/HUE035252T2/en unknown
- 2014-07-25 LT LTEP14755464.6T patent/LT3024829T/lt unknown
-
2016
- 2016-01-07 PH PH12016500044A patent/PH12016500044A1/en unknown
- 2016-01-08 ZA ZA2016/00145A patent/ZA201600145B/en unknown
- 2016-01-22 IL IL243730A patent/IL243730B/en active IP Right Grant
-
2018
- 2018-09-27 US US16/145,073 patent/US10745443B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995001373A1 (en) | 1993-06-29 | 1995-01-12 | Ferring B.V. | Process for manufacture of 1-deamino-8-d-arginine vasopressin |
Non-Patent Citations (2)
| Title |
|---|
| Eur. J. Clin. Pharmacol., Vol. 55, pp. 293-298(1999) |
| J. Med. Chem., Vol. 30, pp. 2245-2252(1987) |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102198130B1 (ko) | 바소프레신-2 수용체 작용제 | |
| EP3151849B1 (en) | Peptides as oxytocin agonists | |
| EP3242882B1 (en) | Cgrp antagonist peptides | |
| US20120129774A1 (en) | Kinin b1 receptor peptide agonists and uses thereof | |
| EP3464324B1 (en) | Angiotensin-1-receptor antagonists | |
| HK1218647B (en) | Vasopressin-2 receptor agonists | |
| US10344054B2 (en) | Angiotensin-1-receptor antagonists | |
| HK40004701A (en) | Angiotensin-1-receptor antagonists | |
| HK40004701B (en) | Angiotensin-1-receptor antagonists | |
| NZ716342B2 (en) | Vasopressin-2 receptor agonists | |
| EA041581B1 (ru) | Антагонисты рецептора ангиотензина-1 | |
| HK1239678B (en) | Cgrp antagonist peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20241229 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| H13 | Ip right lapsed |
Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE Effective date: 20241229 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20241229 |